We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$5.72B
AUM Growth
+$414M
Cap. Flow
+$382M
Cap. Flow %
6.68%
Top 10 Hldgs %
30.61%
Holding
231
New
8
Increased
84
Reduced
36
Closed
15
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$60.4M
2
XRX icon
Xerox
XRX
+$32.5M
3
ABBV icon
AbbVie
ABBV
+$31.3M
4
PAGP icon
Plains GP Holdings
PAGP
+$26.3M
5
UHAL icon
U-Haul Holding Co
UHAL
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.64%
2 Industrials 17.77%
3 Consumer Discretionary 15.58%
4 Financials 10.73%
5 Technology 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PBH icon
126
Prestige Consumer Healthcare
PBH
$2.38B
$5.6M 0.1%
121,125
– –
2013 Q2
8 quarters
HBAN icon
127
Huntington Bancshares
HBAN
$31.3B
$5.49M 0.1%
485,450
– –
2014 Q1
5 quarters
PAY icon
128
DELISTED
Verifone Systems Inc
PAY
$5.49M 0.1%
161,665
– –
2013 Q3
7 quarters
EPAY
129
DELISTED
Bottomline Technologies Inc
EPAY
$5.49M 0.1%
197,360
+10,400
+6% +$287K
2013 Q2
8 quarters
OMCL icon
130
Omnicell
OMCL
$1.63B
$5.33M 0.09%
141,440
-125
-0.1% -$4.56K
2013 Q2
8 quarters
STI icon
131
DELISTED
SunTrust Banks, Inc.
STI
$5.32M 0.09%
123,600
+3,500
+3% +$149K
2014 Q1
5 quarters
ABCO
132
DELISTED
Advisory Board Co
ABCO
$5.19M 0.09%
110,860
+15,250
+16% +$787K
2014 Q4
2 quarters
HPY
133
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
$5.19M 0.09%
95,970
+15
+0% +$787
2014 Q4
2 quarters
ALC icon
134
DELISTED
ASSISTED LIVING CONCEPTS INC NEW CL A COM STK (NV)
ALC
$5.17M 0.09%
71,780
– –
2013 Q2
8 quarters
ACHC icon
135
Acadia Healthcare
ACHC
$2.84B
$5.14M 0.09%
65,690
+10
+0% +$720
2013 Q2
8 quarters
MMSI icon
136
Merit Medical Systems
MMSI
$5.31B
$5.11M 0.09%
237,405
– –
2013 Q2
8 quarters
FUN icon
137
Cedar Fair
FUN
$864M
$5.05M 0.09%
92,720
– –
2014 Q4
2 quarters
WEX icon
138
WEX
WEX
$6.2B
$4.89M 0.09%
42,935
– –
2013 Q2
8 quarters
VRTX icon
139
Vertex Pharmaceuticals
VRTX
$128B
$4.82M 0.08%
39,035
+14,515
+59% +$1.83M
2015 Q1
1 quarter
VTRS icon
140
Viatris
VTRS
$21.2B
$4.8M 0.08%
70,695
-85,430
-55% -$6.04M
2014 Q2
4 quarters
JKHY icon
141
Jack Henry & Associates
JKHY
$10.7B
$4.74M 0.08%
73,320
– –
2013 Q2
8 quarters
STE icon
142
Steris
STE
$21.8B
$4.71M 0.08%
73,050
– –
2013 Q2
8 quarters
GNRC icon
143
Generac Holdings
GNRC
$11.6B
$4.71M 0.08%
118,400
+17,545
+17% +$758K
2013 Q2
8 quarters
APTV icon
144
Aptiv
APTV
$9.5B
$4.68M 0.08%
55,050
– –
2014 Q1
5 quarters
SIRO
145
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$4.57M 0.08%
45,480
– –
2013 Q2
8 quarters
CHD icon
146
Church & Dwight Co
CHD
$24.5B
$4.47M 0.08%
110,100
– –
2013 Q4
6 quarters
BECN icon
147
DELISTED
Beacon Roofing Supply, Inc.
BECN
$4.37M 0.08%
131,460
– –
2013 Q2
8 quarters
SP icon
148
DELISTED
SP Plus Corporation
SP
$4.35M 0.08%
166,655
– –
2013 Q2
8 quarters
CATM
149
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$4.3M 0.08%
116,160
– –
2013 Q2
8 quarters
MRTN icon
150
Marten Transport
MRTN
$1.04B
$4.27M 0.07%
492,130
– –
2013 Q2
8 quarters

Similar funds

Nicholas Company's Q2 2015 Portfolio in Review

As of Q2 2015, Nicholas Company held 231 positions worth $5.72B, up 7.8% from $5.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Nicholas Company deployed $382M of net new capital in Q2 2015, opening 8 new positions and adding to 84 existing holdings. Its largest new stake was Xerox: 1,050,974 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was TEGNA Inc, an estimated $21M trimmed.

  • Nicholas Company's largest Q2 2015 buy was Xerox: 1,050,974 shares worth $29.5M.
  • Nicholas Company added most to Jazz Pharmaceuticals in Q2 2015, an estimated $60.4M increase.
  • Nicholas Company's biggest Q2 2015 reduction was TEGNA Inc, cutting an estimated $21M.
  • Nicholas Company fully exited Stepan Co in Q2 2015, selling an estimated $27.7M.
  • Nicholas Company's ten largest holdings make up 31% of its $5.72B portfolio in Q2 2015.
  • Nicholas Company opened 8 new positions and closed 15 in Q2 2015.
  • Nicholas Company's portfolio value rose 7.8% quarter-over-quarter to $5.72B.

Based on Nicholas Company's 13F filing for Q2 2015, filed 12 Aug 2015.